Designing Publicly Funded Healthcare Markets

Oecd

No 223, OECD Roundtables on Competition Policy Papers from OECD Publishing

Abstract: This paper argues that there is a need for competition agencies to become more active and effective advocates for the use of choice and competition in publicly funded healthcare markets. It suggests that the need for strong regulation will not shrink or disappear, as it might do in a utility, and so advocacy should not focus simply on deregulating, but instead on designing smarter regulations that create markets that incentivise competition on aspects of the service that patients and payers care about most. Drawing on the literature and different examples of pro-competitive reforms that have been undertaken in different countries, it identifies 10 key policy decisions that make a difference when introducing or reforming competitive forces in healthcare markets.It was prepared as a background note for a discussion on the Design of Publicly Funded Healthcare Markets held at the OECD in November 2018.

Date: 2018-10-16
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:oec:dafaac:223-en

Access Statistics for this paper

More papers in OECD Roundtables on Competition Policy Papers from OECD Publishing Contact information at EDIRC.
Bibliographic data for series maintained by ().